Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
APOGEE ENTERPRISES, INC.
SIC 3231 · Glass Products, Made Of Purchased Glass
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
APOGEE ENTERPRISES, INC.
SIC 3231 · Glass Products, Made Of Purchased Glass
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
APOGEE ENTERPRISES, INC.
SIC 3231 · Glass Products, Made Of Purchased Glass
Notes
Support
about
terms
$
APOG
APOGEE ENTERPRISES, INC.
CIK:
0000006845
|
SEC Filings
Cash Flow
Balance Sheet
v3.26.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
May 30, 2026
May 31, 2025
Operating Activities
Net earnings (loss)
$ 11,535
$ (2,688)
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities:
Depreciation and amortization
12,579
12,436
Share-based compensation
2,309
2,300
Deferred income taxes
1,333
2,496
Impairment of long-lived assets
0
7,418
Non-cash lease expense
2,981
3,738
Other, net
(40)
1,622
Changes in operating assets and liabilities:
Receivables
6,339
(3,938)
Inventories
(3,699)
(11,255)
Contract assets
113
2,596
Accounts payable
(15,638)
1,103
Accrued compensation and benefits
(9,225)
(16,639)
Contract liabilities
7,312
8,104
Operating lease liability
(3,430)
(3,643)
Accrued income taxes
1,189
1,698
Other current assets and liabilities
(6,228)
(25,130)
Net cash provided by (used in) operating activities
7,430
(19,782)
Investing Activities
Capital expenditures
(6,289)
(7,167)
Purchases of marketable securities
(4,637)
0
Other, net
1,157
185
Net cash used in investing activities
(9,769)
(6,982)
Financing Activities
Proceeds from revolving credit facilities
33,000
59,000
Repayment on revolving credit facilities
(25,000)
(33,000)
Repayment of term loans
(2,867)
0
Repurchase of common stock
(9,654)
0
Dividends paid
(5,630)
(5,520)
Other, net
(995)
(2,835)
Net cash (used in) provided by financing activities
(11,146)
17,645
Effect of exchange rates on cash
396
502
Decrease in cash and cash equivalents
(13,089)
(8,617)
Cash and cash equivalents at beginning of period
39,523
41,448
Cash and cash equivalents at end of period
26,434
32,831
Non-cash Activity
Capital expenditures in accounts payable
$ 482
$ 922
v3.26.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
May 30, 2026
Feb. 28, 2026
Current assets
Cash and cash equivalents
$ 26,434
$ 39,523
Receivables, net
192,204
198,516
Inventories, net
101,803
98,059
Contract assets
59,344
59,512
Other current assets
50,619
43,823
Total current assets
430,404
439,433
Property, plant and equipment, net
247,763
255,032
Operating lease right-of-use assets
45,633
48,736
Goodwill
236,647
236,744
Intangible assets, net
108,592
111,261
Other non-current assets
32,420
31,139
Total assets
1,101,459
1,122,345
Current liabilities
Accounts payable
86,166
105,478
Accrued compensation and benefits
30,435
39,667
Contract liabilities
68,265
60,903
Operating lease liabilities
14,737
14,729
Other current liabilities
45,002
46,079
Total current liabilities
244,605
266,856
Long-term debt
237,411
232,279
Non-current operating lease liabilities
35,780
39,375
Non-current self-insurance reserves
26,439
24,914
Other non-current liabilities
45,205
47,127
Commitments and contingent liabilities (Note 6)
Shareholders’ equity
Common stock of $0.33-1/3 par value; authorized 50,000,000 shares; issued and outstanding 21,062,901 and 21,220,350, respectively
7,021
7,073
Additional paid-in capital
159,043
159,085
Retained earnings
374,103
376,438
Accumulated other comprehensive loss
(28,148)
(30,802)
Total shareholders’ equity
512,019
511,794
Total liabilities and shareholders’ equity
$ 1,101,459
$ 1,122,345